GLP1R and type 2 diabetes mellitus: Moreover, clinical studies on the treatment of T2D patients with exenatide (synthetic exendin-4) over twelve weeks did not demonstrate clinically meaningful effects on heart rate 157 even though GLP-1R is expressed in heart 158.